The Motley Fool·Mar 8·David DierkingBuy-the-Dip Strategy: Why Total Market Exposure Beats Sector ChasingTotal market ETF strategy outperforms sector chasing during volatility, providing disciplined diversification over tactical rotation. VTIVOOmarket volatilitysector rotation
The Motley Fool·Mar 8·Neil PatelCoca-Cola and Walmart: Dividend Aristocrats Offer Stability Over GrowthCoca-Cola and Walmart offer reliable income through 64 and 53 consecutive years of dividend increases, with yields of 2.72% and 0.78% respectively, though expect limited capital gains. WMTAMZNKOWalmartdividend stocks
The Motley Fool·Mar 8·Reuben Gregg BrewerHealthcare Giants BDX and MDT Offer Dividend Appeal Below $1,000 EachBecton Dickinson and Medtronic offer attractive dividend yields of 2.4% and 2.9%, trading below $1,000 with growth potential amid sector pessimism. MDTISRGBDXdividend stockslong-term investing
The Motley Fool·Mar 8·James HiresThree Blue-Chip Dividend Stocks Offer Compounding Wealth for Long-Term InvestorsThree dividend aristocrats—Pentair, Enterprise Products Partners, and T. Rowe Price Group—offer compelling income and growth opportunities with 117 combined years of consecutive dividend increases. EPDPNRTROWdividend stockslong-term investing
The Motley Fool·Mar 7·Adria CiminoWood's AI Conviction: Ark Doubles Down on CoreWeave and Amazon Amid Tech SelloffCathie Wood's Ark Invest buys CoreWeave and increases Amazon positions during tech selloff, betting AI infrastructure gains from sector weakness. NVDAAMZNCRWVARKKcloud computingAI stocks
The Motley Fool·Mar 7·Dan CaplingerLower-Cost QQQM Offers Invesco's Answer to Its Own Popular QQQ ETFInvesco's newer QQQM ETF matches QQQ's Nasdaq 100 holdings but charges just 0.15% versus QQQ's 0.18%, potentially saving long-term investors meaningful fees. QQQQQQMETFlong-term investing
The Motley Fool·Mar 7·Jason HallBroadcom Positioned as Top Semiconductor Play for Decade-Long InvestorsAnalyst identifies $AVGO as premier chip stock for long-term investors, citing AI-driven growth despite fierce competition from $NVDA and $INTC. NVDAAMDTSMAVGOINTC+2semiconductor stockslong-term investing
The Motley Fool·Mar 6·Marc GubertiThree Growth Stocks Positioned to Double: AI Boom Lifts Chipmakers and FintechThree growth stocks—Robinhood Markets, Micron Technology, and Iren—positioned to double on AI boom tailwinds in fintech, memory chips, and data center infrastructure. MSFTMUHOODIRENfintechdata centers
The Motley Fool·Mar 6·Jason HallCan SoFi Stock Become a Multi-Bagger? Analyst Eyes Decade-Long Growth PathAnalyst suggests $SOFI could deliver significant returns over 10 years despite volatility and Wall Street skepticism about the fintech lender's growth trajectory. SOFIfintechlong-term investing
The Motley Fool·Mar 6·Adria CiminoBuffett's Billion-Dollar Blueprint: Why $VOO Remains His Top Pick for Ordinary InvestorsWarren Buffett champions $VOO, the Vanguard S&P 500 ETF, as the ideal investment for everyday investors seeking long-term wealth. A modest $900 initial investment plus $300 monthly contributions could exceed $1 million over 35 years. AXPBACBACpBBACpEBACpK+16ETFlong-term investing
The Motley Fool·Mar 6·Alex CarchidiWealth's Divergence: Why Billionaires Back Index Funds While Retail Chases CryptoBillionaires favor index funds for steady wealth building while retail investors chase crypto. Index funds likely remain superior for most investors through 2035, though crypto may outperform. SPYcryptocurrencyportfolio diversification
The Motley Fool·Mar 5·Prosper Junior BakinyBristol Myers Squibb and Medtronic Stand Out as Defensive Healthcare Dividend PlaysBMY and MDT offer attractive dividend yields and growth potential, with BMY at 4% yield and MDT boasting 48 years of consecutive increases. BMYCELGrMDTpharmaceuticalsdividend growth
The Motley Fool·Mar 4·Adria CiminoBuffett's Legacy Lives On: Three Blue-Chip Stocks to Emulate His Winning StrategyBuffett's retirement leaves investors with a roadmap: emulate his strategy through Apple, Coca-Cola, and American Express, exemplifying quality competitive moats and dividend growth. AXPAAPLBRK.ABRK.BKOdividend stockslong-term investing
The Motley Fool·Mar 4·Leo SunCoca-Cola and S&P Global Emerge as Premier Dividend Kings for Income InvestorsTwo blue-chip dividend aristocrats offer compelling value: $KO with 64-year streak and 2.6% yield; $SPGI with 53-year streak and strong growth. SPGIKOdividend stockslong-term investing
The Motley Fool·Mar 4·Prosper Junior BakinyBuffett's Dividend Gems: Why Coca-Cola and Visa Deserve Your $1,000Coca-Cola and Visa offer complementary dividend strategies: one with 63 consecutive increase years, the other with 379% payout growth, both from Buffett's portfolio. VBRK.ABRK.BKOdividend stocksdividend growth
The Motley Fool·Mar 4·Matt DilalloThree ETFs Build Lifetime Wealth: A $1,000 Blueprint for Buy-and-Hold InvestorsAnalysis of three ETFs—$SPY, $DGRO, and $BND—recommended as long-term core holdings for buy-and-hold investors seeking portfolio diversification and consistent returns. SPYBNDDGROS&P 500portfolio diversification
The Motley Fool·Mar 4·Alex CarchidiBitcoin's 45% Crash Fueled by Investor Exodus, Not Market ManipulationBitcoin fell 45% amid manipulation allegations, but long-term holder capitulation and ETF redemptions, not concentrated trading schemes, drove the decline. IBITBitcoin crashmarket manipulation
The Motley Fool·Mar 4·Prosper Junior BakinyPharma Giant and Cloud Pioneer Lead Growth Stock Rally Into 2026Analysts spotlight $LLY's obesity drug dominance and $VEEV's cloud expansion as top growth picks for first half 2026. LLYVEEVlong-term investingGLP-1 drugs
The Motley Fool·Mar 3·Matt Frankel, CfpTwo Decades Later: $10K in Vanguard S&P 500 ETF Grows to $78KA $10,000 investment in Vanguard's S&P 500 ETF from 20 years ago would be worth nearly $78,000 today, far exceeding typical retirement savings. VOOVSPFFlong-term investingwealth building
The Motley Fool·Mar 2·Prosper Junior BakinyEli Lilly's Pharma Dominance: Why $LLY Attracts Long-Term Wealth Builders$LLY dominates diabetes and weight management markets while diversifying into oncology and AI, positioning itself as a compelling long-term wealth-building investment within diversified portfolios. NVDALLYlong-term investingdividend reinvestment